Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

1.420 +0.020 (+1.43%)
Streaming Delayed Price Updated: 10:34 AM EST, Dec 9, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 413,427
Open 1.400
Bid (Size) 1.410 (42)
Ask (Size) 1.420 (143)
Prev. Close 1.400
Today's Range 1.380 - 1.420
52wk Range 1.320 - 6.500
Shares Outstanding 198,755,831
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Tech Stocks to Sell Before They Topple in 2023
It's much harder now than in 2021 to find tech stocks to sell, but some tech names are still dramatically overvalued. 
Via InvestorPlace
Ocugen Announces Update on OCU400 Phase 1/2 Clinical Trial Targeting Retinitis Pigmentosa and Leber Congenital Amaurosis
From Ocugen
Via Globe NewsWire

Performance

YTD
-69.92%
-69.92%
1 Month
-13.41%
-13.41%
3 Month
-42.04%
-42.04%
6 Month
-37.44%
-37.44%
1 Year
-76.45%
-76.45%

More News

Read More
Ocugen to Present at 3rd Annual Dry AMD Therapeutics Summit
From Ocugen
Via Globe NewsWire
Why Ocugen Stock Wilted on Wednesday
Via The Motley Fool
Ocugen, Inc. (OCGN) Q3 2022 Earnings Call Transcript
Via The Motley Fool
Why Is Ocugen (OCGN) Stock Up Today?
Via InvestorPlace
3 Stocks to Avoid Right Now
Via The Motley Fool
Why Ocugen Stock Popped by 7% on Tuesday
Via The Motley Fool
SolarEdge Technologies, LivePerson, TaskUs And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Ocugen Provides Business Update & Third Quarter 2022 Financial Results
From Ocugen
Via Globe NewsWire
Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
Via Benzinga
Ocugen Inks US Development Pact For Its Intranasal COVID-19 Vaccine
Via Benzinga
3 High-Octane Growth Stocks With 357% to 571% Upside, According to Wall Street
Via The Motley Fool
Warning! Don’t Even Consider Buying These 7 Dead-Money Stocks
Via InvestorPlace
Ocugen to Host Conference Call on Tuesday, November 8 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2022 Financial Results
From Ocugen
Via Globe NewsWire
Ocugen to Host R&D Day in New York City on Tuesday, November 1, 2022
From Ocugen
Via Globe NewsWire
What Happened With Ocugen Shares During Wednesday's After-Hours Session
Via Benzinga
Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2
From Ocugen
Via Globe NewsWire
What Is Going on With AMTD Digital (HKD) Stock Today?
Via InvestorPlace
Why Missfresh Shares Are Trading Lower; Here Are 30 Stocks Moving Premarket
Via Benzinga
Wall Street Thinks This Top 100 Robinhood Stock Could Skyrocket by 217%
Via The Motley Fool
Ocugen, Inc. to Present at Upcoming Vaccines, Cell & Gene Therapy Conferences
From Ocugen
Via Globe NewsWire
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference
From Ocugen
Via Globe NewsWire
LYFT Stock Alert: What to Know as Lyft Pumps the Brakes on Hiring
Via InvestorPlace
Apple (AAPL) Stock Sinks After Slowing iPhone Production
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.